MicroRNA targeting by quercetin in cancer treatment and chemoprotection

Doo Hwan Kim,Haroon Khan,Hammad Ullah,Sherif T.S. Hassan,Karel Šmejkal,Thomas Efferth,Mohamad Fawzi Mahomoodally,Suowen Xu,Solomon Habtemariam,Rosanna Filosa,Ricardo Lagoa,Kannan RR Rengasamy
DOI: https://doi.org/10.1016/j.phrs.2019.104346
IF: 10.334
2019-01-01
Pharmacological Research
Abstract:A growing number of evidences from clinical and preclinical studies have shown that dysregulation of microRNA (miRNA) function contributes to the progression of cancer and thus miRNA can be an effective target in therapy. Dietary phytochemicals, such as quercetin, are natural products that have potential anti-cancer properties due to their proven antioxidant, anti-inflammatory, and anti-proliferative effects. Available experimental studies indicate that quercetin could modulate multiple cancer-relevant miRNAs including let-7, miR-21, miR-146a and miR-155, thereby inhibiting cancer initiation and development. This paper reviews the data supporting the use of quercetin for miRNA-mediated chemopreventive and therapeutic strategies in various cancers, with the aim to comprehensively understand its health‐promoting benefits and pharmacological potential. Integration of technology platforms for miRNAs biomarker and drug discovery is also presented.
What problem does this paper attempt to address?